CRLF2 overexpression resulting from the described genetic abnormalities is detected in 15% of children with high-risk B-ALL and 47% of pediatric patients with Ph-like B-ALL [55,71]. The gene discussed is CRLF2; the disease is acute lymphoblastic leukemia.